HUGO GOMEZ RUEDA: Open Payments
NPI 1346701455 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,972 in 129 payments from 21 companies in 2025. Trend: 2023 $2,513 · 2024 $5,741 · 2025 $2,972
Food & beverage: $2,972
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $369 |
| Vanda Pharmaceuticals Inc. | 11 | $357 |
| Neurocrine BioSciences, Inc. | 10 | $292 |
| E.R. Squibb & Sons, L.L.C. | 6 | $217 |
| ABBVIE INC. | 13 | $214 |
| Lundbeck LLC | 9 | $206 |
| Otsuka America Pharmaceutical, Inc. | 8 | $196 |
| Axsome Therapeutics, Inc. | 8 | $179 |
| Alkermes, Inc. | 13 | $167 |
| Teva Pharmaceuticals USA, Inc. | 9 | $158 |
Products named: SPRAVATO, HETLIOZ, INGREZZA, REXULTI, VRAYLAR, Auvelity, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
